Cargando…
Interstitial pneumonia associated to peginterferon alpha-2a: A focus on lung function
Pulmonary toxicity related to the use of pegylated interferon alpha-2a during treatment of hepatitis C infections is rare; nonetheless, some cases with fatal outcomes have been reported. Evaluating patients’ pulmonary function is a key to diagnosis, follow-up and prognosis of several respiratory dis...
Autor principal: | Cortés-Telles, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797450/ https://www.ncbi.nlm.nih.gov/pubmed/27051119 http://dx.doi.org/10.4103/0970-2113.177460 |
Ejemplares similares
-
Interferon-alpha-2a/peginterferon: Various toxicities: 6 case reports
Publicado: (2022) -
Concurrent acute interstitial pneumonia and pulmonary embolism during treatment with peginterferon alpha-2a and ribavirin in a patient with hepatitis C
por: Çoban, Hikmet, et al.
Publicado: (2014) -
Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
por: Pouresmaeeli, Mahdiyar, et al.
Publicado: (2015) -
Elasomeran/peginterferon: Autoimmune hepatitis: case report
Publicado: (2022) -
Varicella pneumonia masquerading as interstitial lung disease: Non-specific interstitial pneumonitis
por: Bhat, Rama, et al.
Publicado: (2021)